1. Antibody-drug Conjugate/ADC Related
  2. ADC Linker

ADC Linker

Antibody-drug conjugates (ADCs) are a new class of highly potent biopharmaceutical drugs designed as a targeted therapy for the treatment of people with cancer. ADCs are complex molecules composed of an antibody, a linker and a biological active cytotoxic. ADCs linkers are based on chemical motifs including disulfides, hydrazones or peptides (cleavable), or thioethers (noncleavable) and control the distribution and delivery of the cytotoxic agent to the target cell. Cleavable and noncleavable types of linkers have been proven to be safe in preclinical and clinical trials. A stable link between the antibody and cytotoxic (anti-cancer) agent is a crucial aspect of an ADC.

ADC Linker Related Products (7):

Cat. No. Product Name Effect Purity